Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Phase II Study of Metacavir Enteric-coated Capsules in the Treatment of Chronic Hepatitis B
CTR20131117Phase 2Completed
- Sponsor
- Nanjing Chang'ao Pharmaceutical Technology
- Start
- Aug 2014
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metacavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Nanjing Chang'ao Pharmaceutical Technology. Primary endpoint: Log10 decrease in serum HBV DNA level from baseline at Week 12. Started Aug 2014; status: completed.
02
Drugs
metacavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20131117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131117.